Search results
Found 22818 matches for
Aspirin will be investigated in the world’s largest clinical trial of treatments for patients hospitalised with COVID-19. The RECOVERY trial is taking place in 176 hospital sites across the UK, and has so far recruited over 16,000 patients. Patients with COVID-19 are at higher risk of blood clots forming in their blood vessels. Platelets seem to be hyperreactive in COVID-19 and may be involved in the clotting complications. As an antiplatelet agent, aspirin may reduce the risk of blood clots in patients with COVID-19.
Evelyne Kestelyn
Evelyne Kestelyn - Head of the Clinical Trials Unit
Bridget Wills
Bridget Wills - Professor of Tropical Medicine
Louise Thwaites
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Professor of Experimental Critical Care
Paul Newton
Paul Newton - Professor of Tropical Medicine
Wirichada Pan-ngum
Wirichada Pan-ngum - Associate Professor
Direk Limmathurotsakul
Direk Limmathurotsakul - Professor of Infectious Disease Epidemiology
Richard Hoglund
Richard Hoglund - Head of Pharmacometrics
Mehul Dhorda
Mehul Dhorda - DeTACT-Africa Coordinator / Head of Specimen Management Laboratory
Raph Hamers
MD PhD Raph Hamers - Associate Professor in Infectious Diseases
Stuart Blacksell
BAppSc MPH PhD RBP(ABSA) FASM FFSc(RCPA) TechIOSH Stuart Blacksell - Professor of Tropical Microbiology
Nicholas White
FRS Nicholas White - Professor of Tropical Medicine